Browse by Tags

Help Wanted: Cost-Effectiveness Research For Health And Wellness

National health expenditures represented nearly 18 percent of the U.S. gross domestic product (GDP) in 2015, while efforts to limit cost growth continue to be central objectives for public and private payers alike. Dissemination of research on the evidence...

Published Thu, Mar 03 2017 7:47 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Public Health, Quality, Research, Social Determinants of Health, Population Health, Costs and Spending, cost-effectiveness, comparative effectiveness studies
The Future Of Precision Medicine: Great Promise, Significant Challenges

Editor’s note: This post is part of a series stemming from the Fifth Annual Health Law Year in P/Review event held at Harvard Law School on Monday, January 23rd, 2017. The conference brought together leading experts to review major developments in health...

Published Tue, Feb 02 2017 9:00 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Quality, Research, Featured, Costs and Spending, 21st Century Cures Act, The Health Law Year in P/Review, Precision Medicine, cancer moonshot, cancerr
Gulf War Illness 25 Years After Desert Storm

In the 25 years since Desert Storm, about 250,000 of the almost 700,000 involved in the Gulf War 1 theater have suffered from some version of the complex of symptoms now called Gulf War Illness . This illness was discussed in a recent symposium co-hosted...

Published Thu, Aug 08 2016 9:30 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Public Health, Quality, Research, Veterans, Organization and Delivery, Department of Defense, desert storm, Gulf War Illness, Veterans Administration
To Fight Antimicrobial Resistance, Allow FDA To Approve New Drugs For Limited Populations

Over the past several months, microbiologists and public health experts around the world have been alarmed by the discovery of a gene conferring resistance to colistin, a so-called “last resort” antibiotic. The gene, MCR-1, was discovered in China last...

Published Tue, Apr 04 2016 10:00 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Public Health, Global Health, Quality, Research, Population Health, Featured, Drugs and Medical Technology, FDA, Congress, 21st Century Cures Act, Antibiotic Resistance, Antibiotics, limited-population antibacterial drug, PATH Act, MCR-1
Tamiflu For All? Evidence Of Morbidity In CDC’s Antiviral Guidelines

The Centers for Disease Control and Prevention (CDC) has boiled down its public health campaign against influenza to a single slogan: “Take 3.” Vaccines, everyday preventive actions like handwashing, and influenza antivirals. Last year, because of a mismatch...

Published Thu, Mar 03 2016 11:22 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Public Health, Prevention, Physicians, Global Health, Quality, Research, Drugs and Medical Technology, vaccines, Health Professionals, FDA, drug safety, CDC, clinical trials, influenza
States Taking Action To Break The Link Between Chronic Disease And Maternal Death

It’s shocking that maternal deaths in the U.S. are on the rise, even as they have declined nearly everywhere else in the world. One explanation for this disturbing trend is the increase in chronic conditions — especially hypertension, diabetes,...

Published Fri, Feb 02 2016 10:00 AM by Health Affairs Blog

Filed under: Public Health, States, Quality, Research, Featured, Organization and Delivery, Equity and Disparities, Maternal Health, chronic disease, North Carolina, Georgia, Oklahoma, prenatal care
Reexamining Chronic Fatigue Syndrome Research And Treatment Policy

In recent months, two developments have provided some degree of optimism to people with the illness variously called chronic fatigue syndrome, myalgic encephalomyelitis (“inflammation of the brain and central nervous system, with muscle pain”), CFS/ME...

Published Thu, Feb 02 2016 9:00 AM by Health Affairs Blog

Filed under: Public Health, Quality, Hospitals, Research, Featured, Equity and Disparities, Drugs and Medical Technology, NIH, PACE trial, chronic fatigue syndrome
Palliative Care: Continued Progress But Gaps Remain

The field of palliative care is a relatively recent entrant to the U.S. health care landscape. For those who may not know, palliative care is a new team-based medical specialty that focuses on relief of the pain, symptoms, and stresses of a serious illness...

Published Fri, Oct 10 2015 7:15 AM by Health Affairs Blog

Filed under: Medicare, Access, Quality, Research, Palliative Care, Population Health, Featured, Costs and Spending, Center to Advance Palliative Care, regulations
From The Archives: Deductibles And Out-Of-Pocket Costs

Welcome to “From the Archives,” a new Health Affairs Blog series, where we take a timely topic and delve into the literature and history, from a Health Affairs angle, of course. We recently published a Web First with results from a Kaiser Family Foundation...

Published Tue, Sep 09 2015 9:47 AM by Health Affairs Blog

Filed under: Public Health, Health Care Costs, Quality, Mental Health, Research, Elsewhere@ Health Affairs, Population Health, Featured, Payment Policy, Insurance and Coverage, Organization and Delivery, Costs and Spending, Equity and Disparities, drugs, ACA, chronic disease, Health Affairs journal, From the Archives
The Value And Limits Of Economic Evaluation In Policy Analysis

Health care resources, no matter how represented, are ultimately finite. Trade-offs occur as spending in one area means that those same resources are unavailable to fund another program. In spite of this, U.S. policymakers remain reluctant to engage in...

Published Tue, Sep 09 2015 6:35 AM by Health Affairs Blog

Filed under: Global Health, Quality, Comparative Effectiveness, Research, Population Health, Featured, Payment Policy, Costs and Spending, Medicaid and CHIP, Equity and Disparities, Drugs and Medical Technology, Health Policy, WHO, hepatitis C, health economics, PCORI, heart disease, cost-effectiveness, malaria, QUALY
Avoiding Expensive And Consequential Health Care Decisions Based On Weak Research Designs

Long before Congress created the Health Information Technology for Economic and Clinical Health (HITECH) Act, giving $32 billion to health care providers to transfer to Electronic Health Records (EHR) vendors, plans for that windfall were created by an...

Published Mon, Aug 08 2015 7:25 AM by Health Affairs Blog

Filed under: Health IT, Quality, Technology, Research, Featured, Costs and Spending, Drugs and Medical Technology, Long-term Services and Supports, ONC, ACOs, CDC, HITECH Act, methods
Measuring What Matters: Using Data To Drive Action

Editor’s note: This article is part of a series of blog posts by leaders in health and health care who participated in Spotlight Health from June 25-28, the opening segment of the Aspen Ideas Festival . This year’s theme was Smart Solutions to the World...

Published Fri, Jul 07 2015 10:36 AM by Health Affairs Blog

Filed under: Public Health, Prevention, Quality, Research, Population Health, Featured, Equity and Disparities, RWJF, WHO, culture of health, data, RAND Corporation, Alonzo Plough
To Support Physician Decision-Making, Re-Evaluate Industry Funding Of Science

In 1984, the New England Journal of Medicine ( NEJM ) began requiring authors of research papers to disclose financial relationships with the pharmaceutical or device industry. The policy was controversial then, and even a decade later still faced criticism...

Published Thu, Jul 07 2015 6:25 AM by Health Affairs Blog

Filed under: Physicians, Quality, Research, Featured, Costs and Spending, Drugs and Medical Technology, Health Professionals, NIH, FDA, Industry, Science, NEJM, Cochrane, scientific funding, BMJ, Christopher Robertson
What Does Maximum Transparency Look Like When It Comes To Hospital Ratings?

In our recent paper published in Health Affairs comparing four national hospital ratings, we and our co-authors argued that the lack of agreement among the ratings requires at least two remedies — increasing rating transparency and rethinking the...

Published Fri, May 05 2015 6:23 AM by Health Affairs Blog

Filed under: Quality, Hospitals, Research, Featured, Organization and Delivery, hospital safety, ranking hospitals, hospital ratings, maximum transparency
Health Care Reform And The Trap Of The “Iron Law”

With alarming regularity, many promising pilots in the health care improvement and implementation field have little overall impact when applied more broadly. For example, following early reports that care coordination programs benefit patients and reduce...

Published Wed, Apr 04 2015 9:00 AM by Health Affairs Blog

Filed under: Policy, Quality, Research, Featured, Organization and Delivery, evaluation, Rossi's Iron Law, care delivery, CMMI, quality improvement, health care

Syndication

Recent Posts

Tags

Archives

Help Wanted: Cost-Effectiveness Research For Health And Wellness

The Future Of Precision Medicine: Great Promise, Significant Challenges

Gulf War Illness 25 Years After Desert Storm

To Fight Antimicrobial Resistance, Allow FDA To Approve New Drugs For Limited Populations

Tamiflu For All? Evidence Of Morbidity In CDC’s Antiviral Guidelines

States Taking Action To Break The Link Between Chronic Disease And Maternal Death

Reexamining Chronic Fatigue Syndrome Research And Treatment Policy

Palliative Care: Continued Progress But Gaps Remain

From The Archives: Deductibles And Out-Of-Pocket Costs

The Value And Limits Of Economic Evaluation In Policy Analysis

Avoiding Expensive And Consequential Health Care Decisions Based On Weak Research Designs

Measuring What Matters: Using Data To Drive Action

To Support Physician Decision-Making, Re-Evaluate Industry Funding Of Science

What Does Maximum Transparency Look Like When It Comes To Hospital Ratings?

Health Care Reform And The Trap Of The “Iron Law”